Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes

Jakob R Larsen1, Hans Sjøholm, Tore J Berg

  • 1Diabetes Research Center, Aker and Ulleval University Hospitals, and Department of Pediatrics, Ulleval University Hospital, Oslo, Norway. j.r.larsen@ioks.uio.no

Diabetes Care
|March 30, 2004
PubMed

Insights

Maintaining a mean HbA1c below 8.4% over 18 years preserves cardiac autonomic function in type 1 diabetes patients. Higher HbA1c levels are linked to impaired cardiac autonomic function and dysfunction.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Type 1 diabetes management requires long-term glycemic control.
  • Cardiac autonomic neuropathy is a serious complication of diabetes.
  • The impact of sustained glycemic control on cardiac autonomic function needs further investigation.

Purpose of the Study:

  • To investigate the association between long-term mean HbA1c levels and cardiac autonomic function.
  • To assess cardiac autonomic function in type 1 diabetes patients after 18 years of intensive insulin treatment.

Main Methods:

  • A cohort of 39 type 1 diabetes patients was followed for 18 years with annual HbA1c measurements.
  • Cardiac autonomic function was assessed at 18-year follow-up using heart rate variability (HRV) and standard autonomic function tests.
  • Tests included deep breathing, Valsalva maneuver, tilt test, exercise ECG, and nocturnal heart rate monitoring.

Main Results:

  • Patients with mean HbA1c <8.4% demonstrated significantly better cardiac autonomic function across all tested parameters compared to those with HbA1c ≥8.4%.
  • Heart rate variability during deep breathing was 40% in the low HbA1c group versus 19.9% in the high HbA1c group (P=0.005).
  • The low HbA1c group exhibited a higher heart rate increase during maximal exercise (P=0.001) and lower minimal nocturnal heart rate (P=0.039).

Conclusions:

  • Sustained glycemic control, with a mean HbA1c below 8.4%, is associated with preserved cardiac autonomic function in type 1 diabetes.
  • Elevated mean HbA1c (≥8.4%) over 18 years is linked to impaired cardiac autonomic function and dysfunction.
  • Intensive insulin treatment aiming for lower HbA1c levels may protect against diabetic cardiac autonomic neuropathy.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...